MedNuo Academy | Revue mensuelle de la littérature 2024, numéro 5 – Des besoins cliniques aux progrès de la recherche : Analyse de l’état actuel du carmatinib en traitement de première ligne du CBNPC porteur de la mutation METex14 dans la population chinoise (étude GEOMETRY-C) et diagnostic et traitement du CBNPC porteur de la mutation BRAF V600E – Informations en oncologie
医诺学院|文献月评2024年第五期——从临床需求到研究进展，卡马替尼一线治疗METex14跳突NSCLC中国人群（GEOMETRY-C研究）及BRAF V600E突变NSCLC诊疗现状解读 肿瘤资讯
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
Questions frequentes
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
